Nanomedicine News

RSS

Tekmira’s Lipid Nanoparticle Technology Facilitates Alnylam’s Positive ALN-TTR02 Clinical Results

Tekmira Pharmaceuticals, a company specializing in RNA interference (RNAi) therapeutics, announced that Alnylam Pharmaceuticals has reported its Phase 1 clinical trial results for ALN-TTR02, an RNAi therapeutic that uses Tekmira's lipid nanoparticle delivery platform to target transthyretin (TTR) for TTR-mediated amyloidosis (ATTR) treatment.

17 Jul 2012

Nanolipogels – A Sophisticated Anti-Cancer Drug Delivery System

Yale researchers have developed an anti-cancer drug delivery technique that addresses the challenges in combinatorial drug therapy.

17 Jul 2012

Researchers Design Unique Cancer-Treating Nanomedicine with Reduced Toxicity

A study published in the latest issue of “Proceedings of the National Academy of Sciences (PNAS)” offers a novel approach to cancer treatment by combining supramolecular nanochemistry with drug design.

12 Jul 2012

Merck Licenses PDS Biotechnology’s Versamune Nanotechnology Platform

Merck has inked an exclusive global licensing deal to use PDS Biotechnology’s innovative Versamune nanotechnology platform in Merck’s two investigational antigen-specific cancer immunotherapies that are now in pre-clinical development.

11 Jul 2012

Non-Invasive Method to Effectively Identify Nanoscale Objects and Viruses

Scientists at the Institute for Bioengineering of Catalonia and the University of Barcelona have partnered with the Centro National de Biotecnologia in Madrid and developed a novel technique for identifying nanoscale objects and viruses using an electrostatic force microscope (EFM).

11 Jul 2012

Novavax Presents Preclinical and Clinical Findings for its RSV Vaccine

Novavax, the biopharmaceutical company that develops vaccines for a range of diseases, announced that its Senior Vice President and Chief Medical Officer, Gregory Glenn, M.D., presented the findings of the preclinical and clinical study for Novavax’s respiratory syncytial virus (RSV) vaccine development program at the first conference on Modern Vaccines Adjuvants and Delivery Systems at Copenhagen in Denmark.

From Novavax Inc. 7 Jul 2012

Biomimetic Strategy Developed to Deliver Nanotherapeutics Directly to Blood Clot Site

A novel biomimetic approach for direct delivery of clot-dissolving nanotherapeutics to the site of obstructed blood vessels has been devised by researchers from Harvard University’s Wyss Institute for Biologically Inspired Engineering.

7 Jul 2012

Department of Defense Awards $6.25M to Professor for Innovations in Nanotechnology

Professor Hao Yan from the Arizona State University has been granted a research reward of US $6.25 million to be dispersed over a five-year period by the Department of Defense (DoD) under its Multidisciplinary University Research Initiative (MURI) program.

5 Jul 2012

Nanostructure Platform Paves Way to Transform Gene Regulation Technology

A team of researchers from the fields of nanotechnology and dermatology has used commercial moisturizers based on a nanostructure platform to provide gene regulation technology, which shows promise in developing life-saving therapies to treat skin cancers.

4 Jul 2012

Quantum Dots Can Track Serotonin at the Molecular Level

Researchers at Vanderbilt University have developed a method to tag a protein called the serotonin transporter in human beings at the molecular level. Serotonin is a hormone that regulates appetite, mood and sleep in humans.

30 Jun 2012